| Autor: |
Ravasio, R., Ferrari, F., Musto, P., Locatelli, F. |
| Zdroj: |
Pharmacoeconomics - Italian Research Articles; July 2013, Vol. 15 Issue: 1 p9-17, 9p |
| Abstrakt: |
The expected benefits of biosimilar drugs (a lower price and a competition effect on originators’ price) offer an opportunity to contain the rising trend of the hospital pharmaceutical expenditure. This paper reviews the characteristics of biotechnological products and their regulatory features with the aim to evaluate if and how biosimilars are substituting the originators in the respective markets. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink